Jim Cramer: Positive Pfizer vaccine trial takes ‘impending doom’ off the table
CNBC’s “Squawk on the Street” team discusses the news that Pfizer’s Covid vaccine appears to be 100% effective in 12-
Read moreCNBC’s “Squawk on the Street” team discusses the news that Pfizer’s Covid vaccine appears to be 100% effective in 12-
Read moreThere’s new optimism surrounding Pfizer’s coronavirus vaccine’s ability to fight against the rapidly spreading new variants. CNBC’s Meg Tirrell reports.
Read moreTwo health workers in New York volunteer to be the first people vaccinated in the state. For access to live
Read moreThe U.K. on Wednesday authorized the Pfizer-BioNTech vaccine for emergency use, marking another step in the global battle against the
Read moreDr. Lloyd Minor, dean of Stanford Medicine, joins “Squawk on the Street” to discuss the push for a coronavirus vaccine.
Read moreCNBC’s Meg Tirrell joins “Squawk on the Street” to break down final guidelines on who will get the coronavirus vaccine
Read moreMoncef Slaoui, White House chief advisor of Operation Warp Speed, joins “Squawk on the Street” to discuss developments in a
Read moreCNBC’s Meg Tirrell details the latest in the effort to develop a coronavirus vaccine as Moderna releases interim phase one
Read moreCNBC’s Meg Tirrell delivers the latest on Moderna’s trial of a coronavirus vaccine. Moderna’s closely watched early-stage human trial for
Read moreDaniel Menichella, CEO of CureVac, joins “Squawk on the Street” to discuss how the company could get a vaccine for
Read more